Sigma-Aldrich in distribution deal with MitoProd

US firm Sigma-Aldrich has entered into an agreement with MitoProd SA, a French RNA manufacturing company, to distribute the latter's products  and services worldwide. Under the terms of the accord, MitoProd will  produce custom long RNA oligonucleotides for Sigma-Aldrich customers.  The partnership further expands the US firm's comprehensive custom  oligonucleotide service portfolio.

RNA molecules offer significant promise for a variety of applications in  therapeutics and pharmaceutical development and production. MitoProd  has developed a proprietary technology that enables the in vivo  synthesis of ribonucleic acids. Based on baker yeast fermentation,  MitoProd's technology enables the production of large homogeneous  batches of ribonucleic acids without limitation on length or quantity.

"Sigma-Aldrich's established distribution network will greatly expand  the market for our custom RNA products and services," said Guillaume  Plane, chief executive of MitoProd.